MaxQ AI
About MaxQ AI
MaxQ AI was a medical artificial intelligence company that focused on developing AI-powered clinical decision support tools for acute care settings. Their primary product line, Accipio, utilized deep learning and machine vision to analyze non-contrast head CT scans for the detection and triage of intracranial hemorrhage (ICH), stroke, and brain trauma. The Accipio platform aimed to provide physicians with faster, more accurate insights to improve patient outcomes by prioritizing critical cases and assisting in diagnosis. The company partnered with major healthcare technology providers like GE Healthcare, Philips, Samsung, and IBM Watson to integrate its AI solutions into existing medical workflows and imaging systems.
MaxQ AI’s technology was designed to be highly sensitive in identifying ICH, providing case-level signals for rapid triage and prioritization. Their software suite included modules like Accipio Ix for ICH identification and prioritization, Accipio Ax for slice-level annotation and guided viewing, and Accipio Dxg for triage. The company emphasized improving diagnostic accuracy, reducing missed diagnoses, and ultimately lowering healthcare costs. However, in January 2022, MaxQ AI ceased commercial operations related to its Accipio line of software and shifted its focus away from image analysis-based AI applications requiring regulatory approval. The company intended to build non-image-based AI algorithms to identify anomalies in medical data that could cause poor clinical outcomes or care inefficiencies.
Focus Areas
Business Intelligence
| Technology | Deep learning, machine vision, AI-powered Accipio platform for non-contrast head CT images; utilized Intel AI technologies (Intel Xeon, Intel Core CPUs, Intel Movidius VPUs, OpenVINO toolkit) (historical); shifted to non-image-based AI algorithms (post-pivot) |
What Physicians Need to Know
MaxQ AI's technology aimed to provide physicians with rapid and accurate AI-powered assistance in diagnosing intracranial hemorrhage, stroke, and traumatic brain injury from CT scans. The Accipio platform could prioritize critical cases, reduce the time needed for detection, and offer annotated images and 3D renderings for further analysis, ultimately supporting faster decision-making and potentially improving patient outcomes in acute care settings.
MaxQ AI had distribution agreements and integrations with several key players in the healthcare industry, including Philips, GE Healthcare, IBM Watson Health, Samsung Neurologica, Nuance, TeraRecon, Blackford, and Arterys. Their Accipio platform was designed for native integration into CT and PACS systems, supporting various medical imaging hardware and healthcare clouds.
What the Web Says
MaxQ AI, initially known as MedyMatch, was a healthcare technology company specializing in AI-driven clinical decision support tools for acute care, particularly for detecting brain bleeds in CT scans. The company gained FDA clearance for its Accipio Ix detection platform and partnered with major healthcare technology providers like GE Healthcare, Philips, and Fujifilm. However, MaxQ AI discontinued its Accipio AI software and ceased commercial operations in January 2022, shifting its focus away from image analysis-based AI applications. There is limited recent information available about the company's current status or employer reviews, and many search results for "MaxQ AI" refer to other companies with similar names or AI-related products.
Overall: NegativeStrengths
- FDA clearance for its Accipio Ix detection platform for rapid brain bleed detection.
- Partnerships with major healthcare technology companies (GE Healthcare, Philips, Fujifilm, IBM Watson, Nuance, Blackford) for wider distribution and integration.
- Commitment to high security standards, evidenced by ISO 27001 and 27799 certifications.
- Accipio Clinical Platform generated insights to help provide faster and clinically accurate diagnoses of Intracranial Hemorrhage (ICH).
- Aimed to improve diagnostic accuracy and patient outcomes in emergency and acute care settings.
Limitations
- Discontinued its Accipio AI software and ceased commercial operations in January 2022.
- Shifted away from involvement in image analysis-based AI applications.
- Limited publicly available case studies with quantified outcomes for their AI-driven clinical decision support tools.
- Lack of recent news articles or updates regarding MedyMatch Technology (MaxQ-AI) between April 2022 and April 2025.
- Commercial shutdown left channel partners and healthcare customers without their ICH AI product.
- Operated in a highly competitive niche with many other ICH AI vendors, making it challenging to improve detection without slowing radiologist workflows.
Based on reviews from: indeed.com, maxqintel.com, jobstore.com, reddit.com, capterra.com, prweb.com, aviahealth.com, auntminnie.com, hitconsultant.net, theimagingwire.com, disquiet.io, gartner.com, fiercebiotech.com, g2.com
Last updated: 2026-10-28
Videos
News, demos, and interviews about MaxQ AI.
Videos load interactively. If none appear, search YouTube for MaxQ AI →
Press & Coverage
Frequently Asked Questions
Related Companies
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]
Koios Care is a neurology-focused digital medicine company based in Antwerp, Belgium, specializing in AI-powered platforms. The company aims to revolutionize the management of neurological and chronic conditions, with an initial focus on Parkinson’s Disease. Koios Care’s platform utilizes everyday devices like smartphones and smartwatches to passively collect and analyze data, transforming it into objective, […]
Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]
Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]
CortiCare is a healthcare AI company specializing in neuro telemetry and remote patient monitoring, primarily focusing on electroencephalogram (EEG) services. The company provides telehealth services and an EEG brain monitoring platform to neurology and critical care areas within hospitals, including ICUs, NICUs, PICUs, and EMUs. Their services aim to enhance the neurological assessment of adult, […]